CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 22,557 shares at $1.33 ($30,001)
- 4 Open-market buy Chief Medical Officer bought 22,557 shares at $1.33 ($30,001)
- 4 Open-market buy President & COO bought 18,797 shares at $1.33 ($25,000)
- 4 Open-market buy Director bought 37,594 shares at $1.33 ($50,000)
- 4 Open-market buy Director bought 7,519 shares at $1.33 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 37,594 shares at $1.33 ($50,000)
- 4 Open-market buy Director bought 7,519 shares at $1.33 ($10,000)
- 4 Open-market buy Chief Executive Officer bought 75,188 shares at $1.33 ($100,000)
- 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 3,000 shares at an average $3.19 ($9,580)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 87,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 20 · 395 filings